Veterinary Medicines

WORM STOP tablets for dogs

Authorised
  • Praziquantel
  • Pyrantel embonate
  • Fenbendazole
Download as PDF

Product identification

Medicine name:
WORM STOP tablets for dogs
Worm Stop, Tableta
Active substance:
  • Praziquantel
  • Pyrantel embonate
  • Fenbendazole
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Praziquantel
    50.00
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel embonate
    144.00
    milligram(s)
    /
    1.00
    Tablet
  • Fenbendazole
    200.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AA51
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Package description:
  • Immediate packaging material: PVC/Alu blister or polyethylene container. Package size: carton box containing PVC/Alu blister of 1x2 tablets
  • Immediate packaging material: PVC/Alu blister or polyethylene container. Package size: carton box containing PVC/Alu blister of 3x2 tablets
  • Immediate packaging material: PVC/Alu blister or polyethylene container. Package size: carton box containing PVC/Alu blister of 1x10 tablets
  • Immediate packaging material: PVC/Alu blister or polyethylene container. Package size: carton box containing PVC/Alu blister of 2x10 tablets
  • Immediate packaging material: PVC/Alu blister or polyethylene container. Package size: carton box containing PVC/Alu blister of 10x10 tablets
  • Immediate packaging material: PVC/Alu blister or polyethylene container. Package size: carton box containing PVC/Alu blister of 20x10 tablets
  • Immediate packaging material: PVC/Alu blister or polyethylene container. Package size: Polyethylene container containing 200 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Pharma World Pharmaceuticals Kft.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Pernix Pharma Kft.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 96/079/15-C
Date of authorisation status change:
Reference member state:
  • Hungary
Procedure number:
  • HU/V/0121/001
Concerned member states:
  • Czechia
  • Germany
  • Italy
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 25/07/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 25/07/2023
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 25/07/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."